Yibo Xue

SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer

Yibo Xue, Brian Meehan, Zheng Qing Fu et al. · Nature Communications · 2019 · 189 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

CD44 Promotes PD-L1 Expression and Its Tumor-Intrinsic Function in Breast and Lung Cancers

Tim Kong, Ryuhjin Ahn, Kangning Yang et al. · Cancer Research · 2019 · 162 citations · Full text

Medicine, Cancer Biology, Oncology +17

The CIP2A–TOPBP1 axis safeguards chromosome stability and is a synthetic lethal target for BRCA-mutated cancer

Salomé Adam, Silvia Emma Rossi, Nathalie Moatti et al. · Nature Cancer · 2021 · 120 citations

Life Sciences, Genetics, Molecular Biology +13

CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary

Yibo Xue, Brian Meehan, Elizabeth A. Macdonald et al. · Nature Communications · 2019 · 115 citations · Full text

Medicine, Molecular Biology, Oncology +17

SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria

Yibo Xue, Jordan L. Morris, Kangning Yang et al. · Nature Communications · 2021 · 67 citations · Full text

Life Sciences, Molecular Biology, Oncology +17